Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, Inc. (KYMR), sold 96,000 shares at $32.29 ($3.2M) on 2021-04-12, disclosed to the SEC on 2021-04-12.
Open-market sale of $3.2M KYMR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.81 | 7,616 | $265K | 8.2% |
| 2 | $34.81 | 7,616 | $265K | 8.2% |
| 3 | $35.62 | 2,323 | $83K | 2.6% |
| 4 | $35.62 | 2,323 | $83K | 2.6% |
| 5 | $33.58 | 19,052 | $640K | 19.8% |
| 6 | $33.58 | 19,052 |
| $640K |
| 19.8% |
| 7 | $34.19 | 3,742 | $128K | 4.0% |
| 8 | $34.19 | 3,742 | $128K | 4.0% |
| 9 | $32.29 | 10,362 | $335K | 10.4% |
| 10 | $32.29 | 10,362 | $335K | 10.4% |
| 11 | $33.32 | 4,905 | $163K | 5.1% |
| 12 | $33.32 | 4,905 | $163K | 5.1% |
| Total | $33.62 avg | 96,000 | $3.2M | 100% |
| Filing → |
| KYMR | SELL | 2026-07-02 | $9.2M | — | Filing → |
| KYMR | SELL | 2026-04-29 | $2.4M | — | Filing → |
| KYMR | SELL | 2026-02-25 | $2.7M | — | Filing → |